February 26, 2020
Leiters Readiness to PharMEDium Closure
Dear Valued Customer,
Recently Leiters learned about PharMEDium’s immediate 503B market exit via Amerisource Bergen’s press release1. Click here to read their press release. We understand the immediate shut down and cessation of operations will, unfortunately, create supply disruption for many hospitals and health systems.
Given this industry development, many former PharMEDium customers have been left without product and are reaching out to us with their urgent supply needs. Leiters is currently taking immediate steps to increase production in order to meet what we expect to be significant increased demand in the coming weeks/months.
As part of the ongoing investment in our quality, operations and manufacturing excellence, we began the installation and qualification of an automated syringe line in our state of the art, FDA registered 503B outsourcing facility in Denver, Colorado. The automated syringe line is now fully operational and significantly increases our capacity. This automation allows us to ensure the continued delivery of high-quality operating room (OR) syringes and allows us to meet the increased market demand.
In order to ensure additional support through this transition, we encourage you to reach out to us immediately with a list of products you were purchasing through PharMEDium, along with your monthly forecast. To speak live to one of our representatives please call us at 800.292.6772 or email us at email@example.com.
We are committed to providing the healthcare industry with the highest-quality compounded sterile preparations and stand ready to support your needs now and in the future.
Robin Smith Hoke
President and Chief Executive Officer
1Amerisource Bergen Press Release https://www.businesswire.com/news/home/20200130005132/en/AmerisourceBergen-Reports-Fiscal-2020-Quarter-Results